Medicine and Dentistry
Cervical Cancer
100%
In Vitro
100%
Individualization
100%
Bevacizumab
100%
Vasculotropin
40%
Neoplasm
20%
Metastatic Carcinoma
20%
Cancer Staging
20%
Patient Population
20%
Epithelial Cell
20%
Lymph Duct
20%
Nodal Metastasis
20%
Endostatin
20%
Umbilical Vein
20%
Tumor Progression
20%
Keyphrases
Treatment Personalization
100%
Formation Testing
100%
Tube Length
50%
Cervical Neoplasms
25%
Targeted Tumor Therapy
25%
Human Umbilical Vein
25%
Unselected Patients
25%
Bevacizumab Therapy
25%
Nodal Metastasis
25%
Lymph Vessel Invasion
25%
Cancer Monitoring
25%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
Neoplasm
40%
Vasculotropin
40%
Metastasis
20%
Tumor Growth
20%
Lymph Vessel Metastasis
20%
Endostatin
20%
Cancer Staging
20%